Dr. Charlene Wong works to improve and protect the health of the community

A research collaboration between scientists at Duke University and the University of North Carolina at Chapel Hill has identified and tested an antibody that limits the severity of infections from a variety of coronaviruses, including those that cause COVID-19 as well as the original SARS illness.

In a virtual media briefing with reporters, Dr. Emmanuel Walter Jr., discussed his study findings, the overall vaccine trial process, potential side effects, and the need for herd immunity in American communities.

The National Institute of Allergy and Infectious Diseases (NIAID) has awarded $17.5 million over three years to the Duke Human Vaccine Institute to develop a vaccine that protects against multiple types of coronaviruses and viral variants.

DURHAM, N.C.

The widespread use of masks in schools can effectively prevent COVID-19 transmission and provide a safe learning environment, two Duke scholars said Wednesday.

Researchers have discovered a new coronavirus, found in a child with pneumonia in Malaysia in 2018, that appears to have jumped from dog to human.

A newly identified group of antibodies that binds to a coating of sugars on the outer shell of HIV is effective in neutralizing the virus and points to a novel vaccine approach that could also pote

Hundreds of boxes of protective gear and equipment are now available to health care workers in New Delhi thanks to the quick, coordinated response of Duke Health faculty and staff.

A potential new vaccine developed by members of the Duke Human Vaccine Institute has proven effective in protecting monkeys and mice from a variety of coronavirus infections -- including SARS-CoV-2